Skip to main content
. 2024 Jan 2;30(5):975–983. doi: 10.1158/1078-0432.CCR-23-1829

Figure 4.

Figure 4. OS (A) and PFS (B) for Cohort 2. NE, not evaluable; OS, overall survival; PFS, progression-free survival.

OS (A) and PFS (B) for Cohort 2. NE, not evaluable; OS, overall survival; PFS, progression-free survival.